Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.4.0.6
Consolidated Balance Sheets (USD $)
Sep. 30, 2012
Dec. 31, 2011
Current assets:    
Cash $ 11,211,170 $ 28,644,004
Accounts receivable, net 22,775 15,794
Inventory, net 641,000 821,549
Prepaid expenses and other 298,912 565,174
Total current assets 12,173,857 30,046,521
Property and equipment 1,997,390 1,441,229
Less accumulated depreciation and amortization 1,055,251 977,960
Property and equipment, net 942,139 463,269
Patents and trademarks 112,562 106,592
Less accumulated amortization 21,766 21,171
Patents and trademarks, net 90,796 85,421
Other assets 400,926 598,709
Total assets 13,607,718 31,193,920
Current liabilities:    
Accounts payable 1,970,569 681,754
Accrued liabilities and other 2,103,133 2,097,786
Note payable to investor, current, net of discount of $224,701 2,425,973   
Derivative liabilities, current 509,687 568,930
Total current liabilities 7,009,362 3,348,470
Note payable to investor, net of discounts of $135,186 and $543,612, respectively 3,593,660 6,456,388
Other liabilities 250,588 257,315
Total liabilities 10,853,610 10,062,173
Commitments and contingencies      
Stockholders' equity:    
Preferred stock; $.001 par value; 5,000,000 shares authorized; 6,020 and 9,083 Series B shares and 1,000 Series C shares issued and outstanding at September 30, 2012 and December 31, 2011, respectively 7 10
Common stock; $.001 par value; 200,000,000 shares authorized; 107,370,632 and 95,398,961 shares issued and outstanding at September 30, 2012 and December 31, 2011, respectively 107,371 95,399
Additional paid-in capital 270,001,531 266,393,645
Accumulated deficit (267,354,801) (245,357,307)
Total stockholders' equity 2,754,108 21,131,747
Total liabilities and stockholders' equity $ 13,607,718 $ 31,193,920